Atlas Trials

Phase III, Long-term, Open-label Safety Study of Z-338

Clinical trial NCT01973790 · COMPLETED

Trial details

NCT number
NCT01973790
Sponsor
Zeria Pharmaceutical
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dyspepsia
Start date
2014-03-01
Primary completion
2016-11-01
Enrollment
207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.